In an unprecedented move, U.S. officials have given allowances for cannabis research products to cross the border from Canada to the U.S. Could this herald a change in cannabis regulation for medicinal research?
Research has found cannabis users have a higher resting cortical activity compared to non-users, possibly impairing cognitive processes and the ability to make decisions.
N-propane could be on track to provide a cheaper and easier-to-use alternative to carbon dioxide as a solvent for the process of extracting hemp oil from seeds.
With opioid use disorder (OUD) claiming more lives every year in the U.S., research into the possibility of using cannabis as a therapeutic tool to tackle opioid addiction becomes ever more critical.
Bill could provide a major boost for cannabis research as more cultivators are set to receive licensing approval.
In a controversial move, South Africa becomes the third African country to legalize cannabis cultivation and use in the home.
Ginko Bioworks and Cronos partner to facilitate the future production of lab-grown cannabis.
Terpenes are the relatively unresearched molecules present in cannabis products. Unlocking their potential could provide a whole new array of cannabis uses and benefits.
Novel drug delivery system developed by researchers at CBIS offers a potential fix for those suffering from long-term, acute pain.
With the legalization of cannabis use in Canada looming, concerns are increasing over the risks associated with admitting association with the drug when crossing U.S. border.